Relmada Therapeutics Inc (RLMD)

3.68 -0.04 (-1.08%) USD  |  NASDAQ  |  May 03, 16:00
3.66 -0.02 (-0.54%) After-Hours: 20:00
More

Relmada Therapeutics Capital Expenditures (Quarterly)

Capital Expenditures (Quarterly) Chart

View Capital Expenditures (Quarterly) for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Capital Expenditures (Quarterly) Data

View and export this data back to 2013. Upgrade now.
Date Value
August 31, 2013 --
Date Value
May 31, 2013 --

Capex Definition

Capital expenditures are a line item from a company's statement of cash flows.

Read full definition.

Capital Expenditures (Quarterly) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Capital Expenditures (Quarterly) Benchmarks

Cyclacel Pharmaceuticals Inc Upgrade
Lifecore Biomedical Inc --
Harrow Inc Upgrade
Corvus Pharmaceuticals Inc --
Aquestive Therapeutics Inc Upgrade